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Eradication of poliomyelitis
in South Africa
M. S. Blecher, G. Hussey, G. A. Keen, R. Eggers,
B. Girdler-Brown
An international campaign under the leadership of the
World Health Organisation is underway to eradicate polio
from the world by the year 2000. South Africa may already
be free of polio. However, to ensure eradication we need
to move from a polio control programme to a polio
eradication programme. This necessitates the institution of
a surveillance programme for acute flaccid paralysis (AFP)
and improvement of the delivery of polio vaccine. All
children with AFP (including those with suspected Guillain-
Barre syndrome) should be investigated with stool culture
to exclude polio. Primary care services need strengthening
so that oral polio vaccine coverage greater than 90% is
achieved in all regions by all authorities. Outbreak
response activities need to be developed. Consideration
needs to be given to national immunisation days and
mopping-up activities.
S Afr Med J 1994; 84: 664-668.
In 1977 a milestone was achieved when smallpox became
the first disease to be eradicated globally, following an
11-year eradication campaign.' In 1988 the World Health
Assembly committed the World Health Organisation to the
global er?dication of polio by the year 2000.2 Numerous
other international bodies have committed themselves to the
eradication of polio, including the International Conference
on the Eradication of Disease (1980), the Pan American
Health Organisation (1985), the World Summit for Children
(1990) and the WHO Regional Committee for Africa (1992).3-8
Eradication means the complete elimination of wild
poliovirus and not just the elimination of clinical disease.
Worldwide eradication will enable vaccination against the
disease to be discontinued.
The Department of National Health and Population
Development (DNHPD) has agreed to be part of this
worldwide campaign9.'o and will be initiating a national
eradication campaign in 1994 - 1995. This article aims to
introduce South African practitioners to key issues in the
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international campaign and discusses their relevance to
South Africa.
Global progress in polio
eradication
The last decade has seen a dramatic increase in estimated
global polio vaccine coverage in the first year of life, from
48% in 1985 to 80% in 1992 (WHO - personal
communication)." This is illustrated in Fig. 1. It has been
associated with a progressive decrease in the incidence of
polio reported worldwide, from 56 921 cases in 1981 to
15059 in 1992 (WHO - personal communication)." The
number of countries reporting no polio cases has increased
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Fig, 1. Global immunisation coverage with OPV3 and reported
incidence of poliomyelitis, 1985 - 1992.
The phenomenal success of the campaign in the
Americas has led to the eradication of polio from both
continents (their last case was recorded in 1991'2) and has
provided a significant impetus to the international
eradication programme,
Epidemiology of polio in South
Africa
Notifications for polio in South Africa are shown in Table I
and Fig. 2. The number of cases has been decreasing over
3 decades and our last case of polio was notified in 1991.
Epidemic peaks, such as the 1988 Kwazulu and the 1982
Gazankulu outbreaks, are shown.
Estimates of immunisation coverage with three doses of
oral poliovaccine (OPV-3) for all health regions in 1991 is
shown in Table 11.13 Certain regions such as the Western
Cape have very high coverage (DNHPD - personal
communication). Various surveys have shown low
vaccination coverage, particularly in areas such as Transkei
(55%)," Botshabelo (43%),15 Ingwavuma (48%),'6 Khayelitsha
(56%)17 and QwaQwa (33%).'8 Areas with low coverage are
at particular risk for polio outbreaks and warrant specific
attention in the eradication programme.
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Table I. Poliomyelitis in South Africa - number of cases notified by region, 1980 - 1993
Region 1980 1981 1982 1983 1984 1985 1986 1987 1988 1989 1990 1991 1992 1993
E. Cape 10 13 3 4 7 2 4 0 4 3 0 0 0 0
W. Cape 10 17 6 3 2 18 5 8 11 1 0 0 0 0
N. Cape 4 6 3 2 0 1 0 0 0 2 0 0 0 0
Natal 11 12 6 11 14 0 2 0 17 0 0 0 0 0
OFS 1 0 0 1 1 3 2 0 0 1 0 0 0 0
C. Tvl 14 4 16 9 4 17 18 4 17 1 1 '0 0 0
E. Tvl 3 0 1 1 2 3 1 0 2 0 0 0 0 0
. Tvl 0 1 32 1 0 5 0 0 1 0 0 0 0 0
W. Tvl 0 0 0 0 0 0 2 0 3 0 1 0 0 0
Gazankulu 2 0 270 1 1 1 0 4 7 0 0 0 0 0
KwaZulu 18 63 24 50 24 4 2 4 95 2 0 0 0 0
Lebowa 8 0 72 3 5 14 2 3 15 0 1 1 0 0
KaNgwane 3 0 3 5 1 0 2 1 0 1 0 0 0 0
KwaNdebele 0 0 4 0 0 1 1 0 0 0 0 0 0 0
Qwaqwa 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Bophuthatswana 1 0 37 0 0 1 0 0 0 0 0 0 0 0
Ciskei 7 0 0 0 1 1 0 0 0 0 0 0 0 0
Transkei 20 9 2 1 8 0 0 0 1 1 2 1 0 0
Venda 0 2 2 0 1 1 0 1 1 0 0 0 0 0
Total 112 127 481 92 71 72 41 25 174 12 5 2 0 0
Population (1 000) 29175 29902 30659 31468 32285 33105 33928 34 749 35566 36384 37213 38049 38892 39739
Inc. rate/1 000 000 0,38 0,42 1,57 0,29 0,22 0,22 0,12 0,07 0,49 0,03 0,01 0,01 0,00 0,00
Source: Notifications received by the Directorate: Epidemiology, DNHPD; estimated population fi9ures based on 1991 census (Epidemiological Comments 1993; 20(2): 1-24).
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The WHO is encouraging and assisting countries to
transform their national polio control programmes into
disease eradication programmes. In February 1993 a WHO
mission visited South Africa.'9 According to the WH05
some of the most important strategies for eradication are:
(I) political commitment to ensure resources for eradication;
(iJ) effective surveillance that will detect every case of
poliomyelitis and any circulating wild poliovirus; and
(iiJ) delivery of polio vaccine in the manner most effective at
interrupting transmission of wild poliovirus.
Political commitment
Fig. 2. Annual number of poliomyelitis cases in South Africa,
1960 - 1993.
Table 11. OPV coverage (3rd dose), 1992
Region Coverage (%)
YEAR
Political commitment is essential to achieve the financial
resources and organisational activity necessary for the
eradication programme. South Africa recently became a
signatory of the World Declaration of Children and various
bodies have declared their support for a polio eradication
campaign.920 The non-governmental organisation, Rotary,












Total South Africa 79
Source: Epidemiological Comments 1994; 21 (2).
Surveillance
Surveillance is considered a cornerstone of an effective
polio eradication programme. Surveillance data are
important to identify and monitor areas where poliovirus
persists (or is reimported) as well as areas at high risk. For a
surveillance system to be effective, reporting must be rapid
and complete. Diagnosis must be accurate, so appropriate
case definition and case investigation are important. Teams
must be trained in outbreak response activities, including
active surveillance.
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Case definition
Immediate reporting and detailed investigation of suspected
cases are important. An official case definition of suspected
polio, which will be sensitive enough to detect a high
percentage of possible cases, is required. The current WHO
definitionS is as follows:
A suspected case of polio is any child under 5 years of
age with acute flaccid paralysis (AFP) (including Guillain-
Barre syndrome) for which no other cause can be identified,
or paralytic illness at any age when polio is suspected.
The precise age limit chosen for investigation of AFP
depends on each country's resources; 15 years, until
recently recommended by the WHO, may be more
appropriate for South Africa than the 5-year cut-off. Eighty-
two per cent of all polio notifications received by the
DNHPD for the period 1980 - 1993 were for children under 5
years of age, 95,2% of children were less than 10 years and
98% younger than 15 years (Directorate of Epidemiology,
DNHPD - personal communication).
Reviews of AFP notifications have suggested that the use
of additional diagnostic criteria such ~~ ~gg under 5 years,
the presence of fever at the onset of paralysis, complete
development of paralysis' within 4 days of illness or the
presence of residual paralysis significahtiy improve the
specificity of the WHO definition with only a slight drop in
sensitivity:3.,.
Case investigation
Polio must be actively exCluded as a cause in any child with
AFp'25 AFP may be caused by numerous coriditiOfiS iM!ijtliAg
poliomyelitis, Guillain-Barre syndrome, transverse myelitis,
traumatic neuritis of the sciatic tletve (injections) and
Coxsackie viral infections. AFP may be misdiagl'iOseci as
myojJathies, myositis, trauma or mening()~encepi1aiitis.The
clinical differentiation of various ca'uses of AFP is more fully
discussed elsewhere.25.27
The role of the laboratory is critical to distinguish pOlio
from other causes of AFP. Viral culture of stools is the
recommended test for diagnosis and the WHO recommends
that two specimens be collected 24 - 48 hours apart. While
regional laboratories may do primary culturing, national
laboratories (National Institute of Virology in South Africa) are
usually responsible for subtyping the virus which includes .
differentiating wild from vaccine strains. Serological tests
have, in addition, been used in many countries, although
they are not regarded by the WHO as an essential
component of the programme. Laboratory tests are
discussed in more detail elsewhere. tO.25
Expert review committees, including a paediatrician,
neurologist, virologist and epidemiologist, have been set up
in certain countries to arbitrate on cases of AFP. The most .
recent WHO system for classifying AFP and polio is shown
in Table 111. 23 This system is an improvement on the previous
one25 and should be strongly considered for use in South
Africa.
Most countries have an AFP incidence rate of
approximately 1:100 000 per year in children under 15 years
of age.28 South Africa can .expect approximately 150 cases
of AFP per year in children under 15 years. Each of these
cases of AFP needs to be thoroughly investigated to
exclude polio. Until approximately this number of cases of
AFP is being reported in South Africa, polio surveillance may
be considered deficient. South Africa needs to establish a
surveillance system for AFP and the DNHPD is currently in
the process of making AFP a notifiable condition (as is the
case in many countries).
Table Ill. New classification of AFP in the Americas
1. Confirmed poliomyelitis - acute paralytic illness associated with the
isolation of wild poliovirus, irrespective of residual paralysis.
2. Vaccine-associated poliomyelitis - acute paralytic illness in which
vaccine-like poliovirus is isolated and believed to be the cause of the
disease, This category is separate from confirmed poliomYE!litis with wild
poliovirus isolates.
3. Poliomyelitis compatible - acute paralytic illness with compatible
residual paralysis at 60 days or followed by death or lost to follow-up, in
which at least two adequate stool specimens were not obtained within 2
weeks of the onset of paralysis for examination in differe!1t laboratories.
4. Not poliomyelitis - acute paralytic illness in which a~ least two
adequate slool specimens, obtained within 2 weeks of the onsel of
paralysis, were negative for poliovirus. Aliquots of the original samples
should be held at the laboratory for possible future use. To ensure the
accuracy of this designation, any patient who dies, is lost to follow-up or
has residual paralysis at 60 days should have aliquots of the original
specimens examined in two other laboratories in the PAHO network,
with all the appropriate techniques. If the specimens were adequate and




Outbreak fesponse is defined as the immediate actions to
be taken once a case of polio or AFP is detected. Since
feWer tnan 1%" of persons infected with wild virus develop
paralysis, one case may ge considered an outbreak. All
health authorities should plan responses to a suspected
polio GiJtbreak. I'l'iese may include: (I) rapid case
investigation to determine the diagnosis; (if) active
surveiilance for additional cases such as publicising the
outbreak searches of local hospitals and creches or house-
to-house'searches and testing of stool specimens of
contacts;25ljif) outbreak response immunisation involving
mass immunisation with orv over .- !i,.,-,itAr! aeographlcala llllln ..... _..... _
area conducted rapidly in respOl'ise to detMtiQn of B GB€ie
of polio. Two doses are given 4 - 6 weeks apart mainly t9
children under 5 years of age. Activities cover a
progressively larger circle as cases decline; and (iv) analysis
of the outbreak to determine the cause.
Detailed descriptions of outbreak response activities are
described elsewhere.25.29 Outbreak response (or
'identification-containment') activities proved particularly
efficient in the eradication of smallpox. 3D
Environmental monitoring
Environmental sampling is an attempt to isolate live virus in,
e.g. sewerage and river water. With the elimination of cases,
environmental sampling will remain as the final diagnostic
mechanism of establishing and certifying eradication of
polio.3 It should be conducted in the last stage of the
eradication programme.
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Water and sanitation
Table IV. Incidence of polio and immunisation coverage with OPV-
3 in southern African countries'
Polio is an enterovirus and the main route of transmission is
faecal-oral. Transmission is therefore more frequent in areas
where water supplies and sanitation are poor, and where
overcrowding is rife. Improvements in these areas will assist
the eradication campaign as well as the control of many
other enteric diseases.
OPV is the only vaccine recommended by the WHO
because of its effectiveness in stopping the spread of wild
polioviruses." Several countries use inactivated polio
vaccine (IPV) and some favour the combined use of IPV
followed by OPV. Vaccine efficacy and the OPV versus IPV
debate are discussed in more detail elsewhere.37.36 Polio
vaccine is the most heat-sensitive of all the Expanded
Programme for Immunisation (EPI) vaccines and this


























"Data from the WHO.
'fingerprinting' and epidemiological tracking of particular
polio strains. The recent outbreak of polio in a religious
community in the Netherlands and subsequent isolation of
the identical wild poliovirus in 21 people in an affiliated
community in Alberta, Canada, demonstrate this well.34,35
The reported incidence of polio in countries in southern
Africa is shown in Table IV. The absence of polio in 1992 in
South Africa, Zimbabwe, Botswana, Lesotho, Swaziland,
Namibia and Malawi2S·36 led to speculation that these
southern African countries may already constitute a polio-
free zone. However the 1993 outbreak in Namibia and a
review of AFP cases in Zimbabwe have shown that cases
continue to occur. All countries in the region should increase














Delivery of polio vaccine
Reimporting polio
WHO outlines four main immunisation strategies for the
eradication of wild poliovirus.'
Routine immunisation of all children is the strategy
currently used in South Africa and probably the most
important. Immunisation coverage should be increased to
more than 90% and should be high in all districts. Particular
attention should be focused on areas which currently have
low coverage. Sustaining high levels of coverage will require
strengthening of primary health care infrastructure, training
and support.
National immunisation days entail the immunisation of
all children (usually) under 5 years of age, regardless of
immunisation status. A second dose is given 4 - 6 weeks
later. This strategy has been highly effective in eradicating
polio in Latin America and is strongly supported by the
WHO.3 A recent editorial by Schoub31 strongly motivated a
mass immunisation campaign in South Africa. In developing
countries poor sanitation leads to a higher reproductive rate
of the virus. In addition vaccine efficacy has been shown to
be poorer in these countries.32 With 90% vaccine coverage
and 90% vaccine efficacy, 81 % of children are protected.3
Substantial pools of susceptibles accumulate and
reimportation of wild virus may lead to outbreaks. Schoub31
cites several studies as well as the Kwazulu-Natal epidemic
of 1977/78 where epidemics occurred despite high
immunisation coverage. For these reasons many have
argued that it will not be possible in developing countries to
eradicate polio without mass campaigns.
Mass campaigns are expensive and logistically difficult. If
conducted they should not be considered a substitute for
the expansion of integrated comprehensive primary health
care programmes." The cost-effectiveness of national
immunisation days for South Africa has not yet been
calculated. They are likely to be more cost-effective in
regions with low vaccination coverage and if combined with
other immunisations, e.g. for measles.
Mopping-up is defined as the administration of OPV in
areas at high risk for transmission of wild poliovirus. Vaccine
is given house-to-house to all under-5s regardless of
immunisation status. High-risk areas include those where
any polio case has occurred in the past 3 years, areas where
monitoring of healthy children or environmental monitoring
finds wild poliovirus, areas with a high risk of transmission
such as urban slums and newly developed peri-urban areas,
and areas where immunisation coverage is significantly
below regional averages. Mopping-up is usually reserved for
later stages of eradication programmes where there is only
focal poliovirus circulation.
The fourth strategy, outbreak response immunisation, has
been discussed above.
The lack of synchrony in the implementation of eradication
programmes has led to importations of wild virus into areas
that were considered polio-free. It is partly for this reason
that eradication must be global and the WHO has
encouraged countries to co-operate regionally.
Sophisticated molecular techniques permit the
Stages of eradication campaign
The WHO has a four-stage plan for polio eradication.s In the
early stages of the campaign improvement of routine
immunisation in all local authority areas and the
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development of AFP surveillance systems are particularly
important strategies. South Africa is still at this stage. There
may be a role for a national immunisation campaign,
possibly excluding certain regions with very high vaccination
coverage. If proper AFP surveillance reveals no cases of
confirmed polio we may move rapidly to later stages of the
campaign including more thorough case investigation and
outbreak response activities, mopping-up campaigns and,
finally, environmental monitoring before certification of
eradication. Until global eradication is achieved it will be
essential to maintain high immunisation coverage to protect
against reimported wild virus.
Cost-effectiveness
Polio vaccine costs approximately 7 American cents per
dose.' Globally it has been estimated that the economic
benefits of eradication far exceed the cost and that the
programme will produce savings of US$3 billion by the year
2015. 5•32•38
Conclusions
Polio has no animal reservoirs and thus has the potential to
be eradicated. The global eradication campaign has already
had major successes. The eradication campaign will require
additional resources but international studies indicate that
benefits will far outweigh costs in the long term. The
eradication campaign may have additional spin-ofts
including the improvement of primary health care
infrastructure, infectious disease surveillance and control,
and social mobilisation for health.
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